System | Type | Disorder | Pubmed |
cancer | digestive | liver | |
therapeutic target for eradicating HCC |
cancer | digestive | colon | |
potential therapeutic target for the treatment of colorectal cancer |
cancer | brain | glioma/neuroblstoma | |
silencing DCLK1 induces apoptosis in NB cells |
cancer | digestive | colon | |
potential for developing a therapy for colorectal cancer based on targeting DCLK1-positive tumor stem cells (TSCs) |
cancer | | | |
potential anti‑tumor target via the glucose metabolism pathway |
immunology | infectious | | |
DCLK1 could be a potential therapeutic target for COVID-19, especially in patients with underlying comorbid diseases associated with DCLK1 expression |
cancer | reproductive | breast | |
targeting DCLK1 may become a therapeutic option for breast cancer metastasis |